Business Context and Reporting Period
Lifecore Biomedical, Inc. (LFCR) filed this Form 8-K on April 29, 2024, to report a change in its independent registered public accounting firm. The company is incorporated in Delaware and trades on the NASDAQ Global Select Market.
Financial Metrics
This filing does not contain financial performance data. Revenue, profit, cash flow, margins, debt, and liquidity metrics are not reported in this document.
Material Changes
The primary material change reported is the replacement of the company's independent auditor. The Audit Committee approved the engagement of BDO USA, P.C. effective immediately to perform audit services for the fiscal year ending May 26, 2024.
Guidance, Outlook, and Risks
The filing includes no financial guidance, outlook, or management commentary regarding future performance. Regarding risks and contingencies, the company explicitly stated that during the two most recent fiscal years and the subsequent interim period, there were no consultations with BDO regarding accounting principles, disagreements, or reportable events that influenced the decision to change auditors.
Key Facts for Investor Verification
- New Auditor: BDO USA, P.C. has been engaged as the independent registered public accounting firm.
- Effective Date: The change is effective immediately as of April 29, 2024.
- Audit Scope: BDO will perform audit services for the fiscal year ending May 26, 2024.
- No Disagreements: The company confirmed no disagreements or reportable events occurred with the new auditor prior to engagement.